TransMedics (TMDX) Gains from Investment Securities (2018 - 2019)

TransMedics' (TMDX) quarterly Gains from Investment Securities came in at $614000.0 in Q2 2019, up 192.38% year-on-year from $210000.0 in Q2 2018, and up 324.91% quarter-over-quarter from -$273000.0 in Q1 2019.

TransMedics (TMDX) Gains from Investment Securities (2018 - 2019) Analysis & Trends

TransMedics' Gains from Investment Securities history runs 2 years deep, the most recent figure standing at $614000.0 for Q2 2019.

  • On a quarterly basis, Gains from Investment Securities rose 192.38% year-over-year to $614000.0 in Q2 2019; TTM through Mar 2020 was $614000.0, a 153.72% increase from a year earlier, with the FY2022 full-year figure at $107000.0, changed N/A from the prior year.
  • Gains from Investment Securities improved to $614000.0 in Q2 2019 per TMDX's latest filing, from -$273000.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $614000.0 in Q2 2019 and bottomed at -$273000.0 in Q1 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn
8 Smith & Nephew 26.99 Bn 26.41 Bn -
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn
10 TransMedics 2.56 Bn 2.10 Bn 101.16 Mn

Historic Data

Download Data
DateValue
Jun 29, 2019 614,000.00
Jun 29, 2019 614,000.00
Mar 30, 2019 -273,000.00
Mar 30, 2019 -273,000.00
Dec 29, 2018 122,000.00
Dec 29, 2018 122,000.00
Sep 29, 2018 183,000.00
Sep 29, 2018 183,000.00
Jun 30, 2018 210,000.00
Jun 30, 2018 210,000.00
Mar 31, 2018 30,000.00
Mar 31, 2018 30,000.00